FDA Reports to Congress on Regulatory Science Achievements
In a regulatory science update to Congress, the FDA cited its successes with the use of specialized consortia and improvements in clinical evaluation.
Source: Drug Industry Daily
In a regulatory science update to Congress, the FDA cited its successes with the use of specialized consortia and improvements in clinical evaluation.
Source: Drug Industry Daily